We are live on ! Find out more
CELU icon

Celularity

63 hedge funds and large institutions have $238M invested in Celularity in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,192% more call options, than puts

Call options by funds: $11.6M | Put options by funds: $898K

43% more capital invested

Capital invested by funds: $166M → $238M (+$71.5M)

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

2.95% more ownership

Funds ownership: 5.26%8.21% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 28

2% less funds holding

Funds holding: 6463 (-1)

Holders
63
Holders Change
-1
Holders Change %
-1.56%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
28
Increased
18
Reduced
13
Closed
28
Calls
$11.6M
Puts
$898K
Net Calls
+$10.7M
Net Calls Change
+$9.78M

CELU Hedge Fund Activity: Q1 2021 in Review

63 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2021, worth a combined $238M — up 43% from $166M a quarter earlier.

Fund positioning in CELU was balanced in Q1 2021: 28 funds opened new positions, 28 closed out, 18 added to existing stakes and 13 trimmed.

The largest buyer was W.R. Berkley Corp, adding an estimated $20.4M. The largest seller was HGC Investment Management, exiting entirely with an estimated $7.92M sold.

  • 63 institutional investors held Celularity (CELU) as of Q1 2021, down from 64 in Q4 2020.
  • Funds reported $238M of Celularity stock for Q1 2021, up 43% quarter-over-quarter.
  • 28 funds opened new Celularity positions in Q1 2021 and 28 closed out, a net change of 0 holders.
  • The largest Celularity buyer in Q1 2021 was W.R. Berkley Corp, an estimated $20.4M added.
  • The largest Celularity seller in Q1 2021 was HGC Investment Management, an estimated $7.92M sold.

Based on aggregated 13F filings for Q1 2021.